Showing 5,801 - 5,820 results of 18,540 for search 'significantly ((((((lower decrease) OR (a decrease))) OR (linear decrease))) OR (larger decrease))', query time: 0.70s Refine Results
  1. 5801

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T<sub>regs</sub> notably decreases, indicating the restoration of immune responses. …”
  2. 5802

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T<sub>regs</sub> notably decreases, indicating the restoration of immune responses. …”
  3. 5803

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…After coincubation with edited CMCs, the proportions of CD8+CD69+ and CD8+CD44+ T cells significantly increase, while the proportion of CD4+Foxp3+ T<sub>regs</sub> notably decreases, indicating the restoration of immune responses. …”
  4. 5804

    Demographic and clinical data at baseline. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  5. 5805

    Changes in clinical variables. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  6. 5806
  7. 5807
  8. 5808
  9. 5809
  10. 5810
  11. 5811
  12. 5812

    Unraveling the Anticancer Potential of SSRIs in Prostate Cancer by Combining Computational Systems Biology and <i>In Vitro</i> Analyses by Sanaa K. Bardaweel (9636542)

    Published 2025
    “…The combination of SSRIs with cisplatin, 5-fluorouracil, and raloxifene resulted in either synergistic or additive effects. SSRIs resulted in a significant increase in the early and late apoptotic activity in PC3 cells. …”
  13. 5813
  14. 5814
  15. 5815
  16. 5816
  17. 5817
  18. 5818
  19. 5819
  20. 5820